Publications by authors named "Yuyong Su"
Article Synopsis
- TNF inhibitors like adalimumab and infliximab are crucial for treating severe autoimmune diseases but can have side effects.
- A study analyzed adverse drug reactions (ADRs) from these medications using WHO's VigiAccess database to determine which had the least risk for patients.
- The results revealed over 1.4 million adverse events, with infections being the most common type, highlighting the need for careful patient-specific medication choices.
Objective: To explore the practice of comprehensive pharmacy management mode under the strategy of healthy China.
Methods: Combining with hospital practice, the advantages and disadvantages of comprehensive pharmacy management mode were discussed and considered.
Results: The comprehensive pharmacy has advantages in improving work efficiency, optimizing resource allocation, refining pharmacy management, checking the compatibility of Chinese and Western medicines, and improving service quality, and it also increases the labor intensity of staff and is prone to prescription dispensing errors.
Purpose: Researches revealed that probiotics maybe a potential strategy for COVID-19, whereas there is a lack of related evidence. This study aims to analyze the role of probiotics on severe COVID-19 patients.
Methods: In the current retrospective single-center study, we collected data of 311 consecutive severe patients with confirmed COVID-19 in Wuhan Union Hospital from Feb 3rd to Feb 20th, 2020.
Introduction: Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) swept rapidly throughout the world. So far, no therapeutics have yet proven to be effective. Ribavirin was recommended for the treatment of COVID-19 in China because of its in vitro activity.
View Article and Find Full Text PDFType 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by inflammation of pancreatic islets and destruction of β cells. Up to now, there is still no cure for this devastating disease and alternative approach should be developed. To explore a novel gene therapy strategy combining immunotherapy and β cell regeneration, we constructed a non-viral plasmid encoding proinsulin (PI) and pancreatic regenerating (Reg) III protein (pReg/PI).
View Article and Find Full Text PDF